Filing Details

Accession Number:
0001104659-12-058850
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-20 12:33:28
Reporting Period:
2012-08-17
Filing Date:
2012-08-20
Accepted Time:
2012-08-20 12:33:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Trovagene Inc. TROV Biological Products, (No Disgnostic Substances) (2836) 043721895
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253803 Gabriel Cerrone C/O Synergy Pharmaceuticals Inc.
420 Lexington Avenue, Suite 1609
New York NY 10170
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-17 300 $2.15 672,026 No 4 P Indirect By Panetta Partners, Ltd.
Common Stock Acquisiton 2012-08-20 7,500 $2.36 679,526 No 4 P Indirect By Panetta Partners, Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Panetta Partners, Ltd.
No 4 P Indirect By Panetta Partners, Ltd.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,250 Direct
Footnotes
  1. Mr. Cerrone is the sole managing partner of Panetta Partners, Ltd. and in such capacity exercises voting and dispositive control over securities owned by Panetta despite him having only a small pecuniary interest in such securities.